비교리스트

 카트 문의
시장보고서
상품코드
1662074

세계의 차세대 시퀸서 시장

Next Generation Sequencers
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 299 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 차세대 시퀸서 시장은 2030년까지 433억 달러에 도달

2024년에 166억 달러로 추정되는 차세대 시퀸서 세계 시장은 2024-2030년간 CAGR 17.3%로 성장하여 2030년에는 433억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 차세대 시퀸서 소모품은 CAGR 17.1%를 나타내고, 분석 기간 종료까지 266억 달러에 이를 것으로 예측됩니다. 차세대 시퀸서 플랫폼 부문의 성장률은 분석 기간중 CAGR 16.2%를 나타낼 전망입니다.

미국 시장은 45억 달러로 추정, 중국은 CAGR 22.8%로 성장 예측

미국의 차세대 시퀸서 시장은 2024년에 45억 달러에 이른 것으로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 100억 달러 규모에 이를 것으로 예측되며, 분석 기간인 2024-2030년간 CAGR은 22.8%를 나타낼 전망입니다. 기타 주목해야 할 지역별 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 13.0%와 15.2%를 나타낼 것으로 예측됩니다. 유럽에서는 독일이 CAGR 약 13.7%로 성장할 것으로 예측됩니다.

세계의 차세대 시퀸서 시장 - 주요 동향과 촉진요인 정리

2005년에 시작된 차세대 염기서열 분석(NGS) 기술은 여러 개의 DNA 염기서열을 동시에 시퀀싱할 수 있게 함으로써 기존의 싱거 시퀀싱을 크게 발전시켜 유전학 분야에 혁명을 불러일으켰습니다. 초기에 '초병렬 시퀀싱'이라고 불렸던 이 기술은 전례 없는 속도와 비용 절감을 실현하여 광범위한 유전체 연구를 보다 친숙하게 만들었습니다. Sanger 시퀀싱은 그 정확성 때문에 여전히 소규모 프로젝트나 NGS 결과 검증을 위해 사용되고 있지만, NGS는 효율성과 확장성이 뛰어나 한 번의 실행으로 다양한 샘플에 걸쳐 수백에서 수천 개의 유전자를 분석할 수 있습니다. 돌연변이 및 RNA 융합까지 광범위한 유전체 특징을 검출하여 이전에는 불가능했던 광범위한 유전자 분석을 용이하게 합니다.

NGS가 돋보이는 것은 처리량이 많을 뿐만 아니라 필요한 샘플량이 적고, 정확도가 높으며, 희귀한 유전자 변이를 검출할 수 있다는 점입니다. 이러한 특성으로 인해 의료, 농업, 환경 과학 등 다양한 분야에서 필수적인 도구가 되어 유전체 연구, 임상 진단, 법의학 수사가 발전하고 있으며, NGS의 과정은 복잡하며, DNA 또는 cDNA 샘플을 조각화하여 쉽게 식별할 수 있도록 고유한 분자 어댑터에 연결하는 시퀀싱 라이브러리를 구축하는 것으로 시작됩니다. 라이브러리 구축으로 시작됩니다. 그 후, "합성 시퀀싱" 접근법을 채택하는 기술을 사용하여 시퀀싱 중 신호 검출을 강화하기 위해 고체 표면에서 DNA 조각을 복제 증폭합니다. 이 과정에 관여하는 장치는 광학 신호 또는 Ion Torrent 기술과 같이 DNA 합성 중에 방출되는 수소 이온에 의해 생성되는 전기적 신호에 의해 각 뉴클레오티드의 추가를 감지합니다. 데이터 분석 단계는 복잡하며, 원시 염기서열 데이터를 가치 있는 유전학적 통찰력으로 변환하기 위한 여러 단계의 해석을 포함합니다.

다양한 분야에서 NGS가 광범위하게 적용되고 있는 것은 높은 처리량, 속도, 비용 효율성이라는 NGS의 장점을 뒷받침합니다. 임상 연구에서 NGS는 질병과 관련된 유전적 돌연변이를 찾아내어 표적 치료의 길을 열어주며, 유전자 이상 선별을 통해 생식 의학에 중요한 역할을 하고 있습니다. 농업 분야에서는 식물 유전학 연구를 촉진하여 작물 개량을 가속화하고 더 건강한 작물 품종을 재배할 수 있도록 돕고 있으며, NGS는 코로나19 팬데믹과 같은 세계 보건 비상사태에서 신속한 바이러스 유전체 시퀀싱을 통해 돌연변이 추적과 백신 개발을 지원함으로써 특히 중요한 역할을 하고 있습니다. NGS의 미래는 클라우드 컴퓨팅과의 통합, 바이오인포매틱스 발전, 개인 맞춤형 의료에 대한 소비자의 관심 증가, 학술 및 임상 연구 확대, 규제 및 윤리적 프레임워크의 진화, 전략적 제휴, 신흥 시장에 대한 투자 증가 등의 성장 촉진요인에 힘입어 성장할 것입니다. 요인에 힘입어 개인맞춤형 의료 및 연구개발 등을 강화할 것으로 예상됩니다.

부문

제품(소모품, 플랫폼, 서비스) ;& 최종사용자(학술기관 및 연구센터, 병원 및 클리닉, 제약 및 생명공학 기업, 기타 최종사용자)

조사 대상 기업 예(주요 93개사)

  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Fluidigm Corporation
  • Illumina Inc.
  • Oxford Gene Technology
  • Oxford Nanopore Technologies
  • Pacific Biosciences of California Inc.
  • QIAGEN N.V.
  • RainDance Technologies Inc.
  • Roche Sequencing
  • Thermo Fischer Scientific Inc.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 25.03.11

Global Next Generation Sequencers Market to Reach US$43.3 Billion by 2030

The global market for Next Generation Sequencers estimated at US$16.6 Billion in the year 2024, is expected to reach US$43.3 Billion by 2030, growing at a CAGR of 17.3% over the analysis period 2024-2030. Next Generation Sequencer Consumables, one of the segments analyzed in the report, is expected to record a 17.1% CAGR and reach US$26.6 Billion by the end of the analysis period. Growth in the Next Generation Sequencer Platforms segment is estimated at 16.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.5 Billion While China is Forecast to Grow at 22.8% CAGR

The Next Generation Sequencers market in the U.S. is estimated at US$4.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$10.0 Billion by the year 2030 trailing a CAGR of 22.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 13.0% and 15.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.7% CAGR.

Global Next Generation Sequencers Market - Key Trends and Drivers Summarized

Next-Generation Sequencing (NGS) technologies, initiated in 2005, have revolutionized the field of genetics by allowing for the simultaneous sequencing of multiple DNA strands, a significant advancement over the traditional Sanger sequencing. This technology, originally dubbed "massively-parallel sequencing," offers unprecedented speed and reduced costs, making extensive genomic studies more accessible. While Sanger sequencing is still utilized for smaller projects or to validate NGS results due to its high accuracy, NGS excels in efficiency and scalability, analyzing hundreds to thousands of genes across various samples in a single run. NGS detects a wide range of genomic features from single nucleotide variants to complex structural variations and RNA fusions, facilitating extensive genetic analyses that were previously unfeasible.

NGS stands out not just for its volume handling but also for its lower sample requirements, higher accuracy, and the ability to detect rare genetic variants. These attributes make it an essential tool in diverse fields such as medicine, agriculture, and environmental science, advancing genomic research, clinical diagnostics, and forensic investigations. The NGS process is intricate, beginning with the construction of a sequencing library where DNA or cDNA samples are fragmented and linked to unique molecular adaptors for easy identification. This is followed by clonal amplification of the DNA fragments on a solid surface to enhance signal detection during sequencing, using technologies that employ a 'sequencing by synthesis' approach. Instruments involved in this process detect each nucleotide addition either through optical signals or, as in Ion Torrent technology, electrical signals produced by hydrogen ions released during DNA synthesis. The data analysis phase is complex, involving multiple stages of interpretation to transform raw sequencing data into valuable genetic insights.

The broad application of NGS across various sectors underscores its advantages of high throughput, speed, and cost-efficiency. In clinical research, NGS aids in identifying genetic variations associated with diseases, paving the way for targeted therapies and playing a vital role in reproductive health through genetic anomaly screenings. In agriculture, it accelerates crop improvement by facilitating plant genetic studies, leading to the cultivation of more robust crop varieties. NGS has been particularly crucial during global health emergencies, such as the COVID-19 pandemic, by enabling rapid viral genomic sequencing, which assists in tracking mutations and vaccine development. The future of NGS looks promising with ongoing advancements expected to enhance personalized medicine, agricultural development, and more, fueled by growth drivers such as integration with cloud computing, advancements in bioinformatics, rising consumer interest in personalized medicine, expanding academic and clinical research, evolving regulatory and ethical frameworks, strategic collaborations, and increased investments in emerging markets.

SCOPE OF STUDY:

The report analyzes the Next Generation Sequencers market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Consumables, Platforms, Services); End-Use (Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 93 Featured) -

  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Fluidigm Corporation
  • Illumina Inc.
  • Oxford Gene Technology
  • Oxford Nanopore Technologies
  • Pacific Biosciences of California Inc.
  • QIAGEN N.V.
  • RainDance Technologies Inc.
  • Roche Sequencing
  • Thermo Fischer Scientific Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global EconomicUpdate
    • Next Generation Sequencers - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advancements in Sequencing Technologies Expand Addressable Market Opportunity
    • Increased Adoption in Clinical Diagnostics Throws the Spotlight on Sequencing Applications
    • Rising Demand for Personalized Medicine Drives Adoption of NGS
    • Integration with Artificial Intelligence and Big Data Analytics Generates New Opportunities
    • Technological Innovations in Sample Preparation and Library Construction Spur Growth
    • Growing Utilization in Oncology Research Expands Market Potential
    • Emergence of Single-Cell Sequencing Drives Adoption of Advanced NGS Technologies
    • Focus on Rare Disease Diagnostics Generates Demand for High-Throughput Sequencing
    • Development of Portable and Real-Time Sequencing Devices Expands Addressable Market
    • Rising Investments in Genomic Research Strengthens Market Demand
    • Adoption of NGS in Infectious Disease Surveillance Generates New Opportunities
    • Consumer Demand for Ancestry and Genetic Testing Drives Market Adoption
    • Integration with CRISPR and Gene Editing Technologies Generates Demand for NGS
    • Focus on Precision Medicine and Targeted Therapies Strengthens Business Case for NGS
    • Emerging Applications in Microbiome Research Propel Growth in NGS Utilization
    • Challenges in Regulatory Compliance and Quality Control
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Next Generation Sequencers Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Next Generation Sequencers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Next Generation Sequencers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Next Generation Sequencers by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Platforms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Platforms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Platforms by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Academic Institutes & Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Academic Institutes & Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Academic Institutes & Research Centers by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Pharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Pharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Pharmaceutical & Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Next Generation Sequencers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Next Generation Sequencers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Next Generation Sequencers by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Next Generation Sequencers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Next Generation Sequencers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Next Generation Sequencers by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Next Generation Sequencers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Next Generation Sequencers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Next Generation Sequencers by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Next Generation Sequencers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Next Generation Sequencers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Next Generation Sequencers by Geographic Region - Percentage Breakdown of Value Revenues for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제